Italia markets open in 1 hour 20 minutes
Dow Jones
38.686,32 +574,82 (+1,51%) Nasdaq
16.735,02 -2,08 (-0,01%) Nikkei 225
38.970,76 +482,86 (+1,25%) EUR/USD
1,0855 +0,0001 (+0,01%) Bitcoin EUR
63.266,92 +848,89 (+1,36%) CMC Crypto 200
1.481,56 +52,99 (+3,71%)
NVCR Sep 2024 12.500 call
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
In data: 10:58AM EDT. Mercato aperto.
| Chiusura precedente | 7,65 |
| Aperto | 7,65 |
| Denaro | 0,00 |
| Domanda | 0,00 |
| Prezzo d'esercizio | 12,50 |
| Scadenza | 2024-09-20 |
| Min-Max giorno | 7,65 - 7,65 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | N/D |
GlobeNewswireZai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in
© 2024 Yahoo. Tutti i diritti riservati.